WellPoint Cancer Drug Pathways Program Aims To Save 4% In Annual Costs
This article was originally published in The Pink Sheet Daily
Executive Summary
When it is fully operational in all 14 WellPoint states, more than 21 million members will be eligible for the initiative to standardize cancer prescribing and lower drug costs.